Lanzamiento Enero 2027

Metaanálisis2016

Efficacy of omega-3 highly unsaturated fatty acids in the treatment of depression

Hallahan B, Ryan T, Hibbeln JR, Murray IT, Glynn S, Ramsden CE, SanGiovanni JP, Davis JM

The British journal of psychiatry : the journal of mental science · 136 citas

Cómo se estudió

Diseño
Metaanálisis (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
National Institutes of Health
Gobierno
Intramural NIH HHS
Subvenciones
National Institutes of Health (Z01 AA000115)

Según 2 financiadores declarados.

Publicación

Publicado
2016-04-22 · Br J Psychiatry · vol. 209 · número 3 · págs. 192–201
Editorial
Cambridge University Press
Citado
189 citas · más que el 100% de estudios similares · 18.8× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
86 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Fatty Acid Research and Health · Tryptophan and brain disorders · Treatment of Major Depression
Palabras clave
Docosahexaenoic acid, Depression (economics), Placebo, Eicosapentaenoic acid, Internal medicine, Randomized controlled trial, Clinical trial, Meta-analysis, Medicine, Psychiatry, Psychology, Fatty acid, Polyunsaturated fatty acid, Alternative medicine, Biology
MeSH
humans, fatty acids, omega-3, docosahexaenoic acids, eicosapentaenoic acid, major depressive disorder

8 autores

  • Brian P. Hallahan🇮🇪🇺🇸 · autor de correspondenciaOllscoil na Gaillimhe – University of Galway; University of Illinois Chicago; National Institute on Alcohol Abuse and Alcoholism
  • Timothy J. Ryan🇺🇸University of Illinois Chicago; National Institute on Alcohol Abuse and Alcoholism
  • Joseph R. Hibbeln🇺🇸National Institutes of Health; University of Illinois Chicago; National Institute on Alcohol Abuse and Alcoholism
  • Ivan T. Murray🇮🇪🇺🇸University Hospital Galway; University of Illinois Chicago; National Institute on Alcohol Abuse and Alcoholism
  • Shauna Glynn🇺🇸University of Illinois Chicago; National Institute on Alcohol Abuse and Alcoholism
  • Christopher E. Ramsden🇺🇸National Institutes of Health; University of Illinois Chicago; National Institute on Alcohol Abuse and Alcoholism
  • John Paul SanGiovanni🇺🇸National Institutes of Health; University of Illinois Chicago; National Institute on Alcohol Abuse and Alcoholism
  • John M. Davis🇺🇸University of Illinois Chicago; National Institute on Alcohol Abuse and Alcoholism

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Trials evaluating efficacy of omega-3 highly unsaturated fatty acids (HUFAs) in major depressive disorder report discrepant findings.

Aims

To establish the reasons underlying inconsistent findings among randomised controlled trials (RCTs) of omega-3 HUFAs for depression and to assess implications for further trials.

Method

A systematic bibliographic search of double-blind RCTs was conducted between January 1980 and July 2014 and an exploratory hypothesis-testing meta-analysis performed in 35 RCTs including 6665 participants receiving omega-3 HUFAs and 4373 participants receiving placebo.

Results

Among participants with diagnosed depression, eicosapentaenoic acid (EPA)-predominant formulations (>50% EPA) demonstrated clinical benefits compared with placebo (Hedge's G = 0.61, P50% DHA) did not. EPA failed to prevent depressive symptoms among populations not diagnosed for depression.

Conclusions

Further RCTs should be conducted on study populations with diagnosed or clinically significant depression of adequate duration using EPA-predominant omega-3 HUFA formulations.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.